Catalysts for Sandoz Inc
291 tracked
Oct 9, 2025
approval
TRAVATAN Z (TRAVOPROST) — FDA approval
TRAVOPROST
→
Oct 8, 2025
approval
TRIAMCINOLONE ACETONIDE — FDA approval
triamcinolone acetonide Rising
→
Oct 1, 2025
approval
PANTOPRAZOLE SODIUM — FDA approval
PANTOPRAZOLE SODIUM
→
Oct 1, 2025
approval
PANTOPRAZOLE SODIUM — FDA approval
PANTOPRAZOLE SODIUM
→
Oct 1, 2025
approval
PANTOPRAZOLE SODIUM — FDA approval
PANTOPRAZOLE SODIUM
→
Sep 24, 2025
recall
Sandoz Inc recall (Cls II)
Sandoz Inc
→
Sep 23, 2025
approval
AZSTARYS (DEXMETHYLPHENIDATE HYDROCHLORIDE) — FDA approval
Sandoz Inc
→
Sep 23, 2025
approval
RITALIN LA (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
RITALIN LA
→
Sep 23, 2025
approval
LEUPROLIDE ACETATE — FDA approval
LEUPROLIDE ACETATE
→
Sep 23, 2025
approval
FOCALIN XR (DEXMETHYLPHENIDATE HYDROCHLORIDE) — FDA approval
dexmethylphenidate hydrochloride ER
→
Sep 22, 2025
approval
IRON SUCROSE — FDA approval
succharated ferric oxide
→
Sep 17, 2025
recall
Sandoz Inc recall (Cls II)
Sandoz Inc
→
Aug 8, 2025
approval
IRON SUCROSE — FDA approval
succharated ferric oxide
→
Aug 1, 2025
approval
METHYLPREDNISOLONE — FDA approval
MEDROL
→
Aug 1, 2025
approval
METHYLPREDNISOLONE — FDA approval
MEDROL
→
Aug 1, 2025
approval
METHYLPREDNISOLONE — FDA approval
MEDROL
→
Jul 29, 2025
approval
HYRIMOZ (ADALIMUMAB-ADAZ) — FDA approval
HYRIMOZ
→
Jul 15, 2025
approval
DUREZOL (DIFLUPREDNATE) — FDA approval
DIFLUPREDNATE
→
Jul 9, 2025
recall
Sandoz Inc recall (Cls I)
Sandoz Inc
→
Jul 9, 2025
recall
Sandoz Inc recall (Cls I)
Sandoz Inc
→
May 20, 2025
approval
HYRIMOZ (ADALIMUMAB-ADAZ) — FDA approval
HYRIMOZ
→
Mar 7, 2025
approval
GLATOPA (GLATIRAMER ACETATE) — FDA approval
GLATIRAMER ACETATE
→
Mar 7, 2025
approval
GLATOPA (GLATIRAMER ACETATE) — FDA approval
GLATIRAMER ACETATE
→
Feb 12, 2025
approval
METHYLPREDNISOLONE ACETATE — FDA approval
METHYLPREDNISOLONE ACETATE
→
Feb 12, 2025
approval
METHYLPREDNISOLONE ACETATE — FDA approval
METHYLPREDNISOLONE ACETATE
→
Feb 10, 2025
approval
ENZEEVU (AFLIBERCEPT-ABZV) — FDA approval
aflibercept biosimilar
→
Dec 19, 2024
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Oct 24, 2024
approval
JUBBONTI (DENOSUMAB-BBDZ) — FDA approval
JUBBONTI
→
Sep 27, 2024
approval
AMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approval
UNASYN
→
Aug 22, 2024
approval
AMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approval
UNASYN
→